Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Ds-HMGB1 and fr-HMGB induce depressive behavior through neuroinflammation in contrast to nonoxid-HMGB1.
High-resolution three-dimensional macromolecular proton fraction mapping for quantitative neuroanatomical imaging of the rodent brain in ultra-high magnetic fields.
Immune response genes receptors expression and polymorphisms in relation to multiple sclerosis susceptibility and response to INF-β therapy.
Mycophenolate Mofetil as a Monotherapy in Multiple Sclerosis: a multicentre retrospective study on 361 patients
Analysis of the neuroregenerative activities of mesenchymal stem cells in functional recovery after rat spinal cord injury.
Optic neuritis in multiple sclerosis: Looking from a patient's eyes.
The influence of gut-derived CD39 regulatory T cells in CNS demyelinating disease.
An oral NaV1.8 blocker improves motor function in mice completely deficient of myelin protein P0.
HIV-1 Tat Inhibits Autotaxin Lysophospholipase D Activity and Modulates Oligodendrocyte Differentiation.
Inadequate outcome measures are the biggest impediment to successful clinical trials in progressive MS - YES.
Fingolimod promotes peripheral nerve regeneration via modulation of lysophospholipid signaling.
Salt intake in multiple sclerosis: friend or foe?
Endocannabionoid System in Neurological Disorders.
The axon as a physical structure in health and acute trauma.
Peptidyl Aldehyde Specifically Interacts with Immunosubunit β1i Proteasome: In Vitro and In Vivo Effects.
Humoral response against myelin associated glycoprotein reflects oligodendroglial degeneration in Parkinson's disease.
Survival and Functionality of Human Induced Pluripotent Stem Cell-Derived Oligodendrocytes in a Nonhuman Primate Model for Multiple Sclerosis.
Should the symptomatic region be included in dissemination in space in MRI criteria for MS?
Multiple sclerosis: Dimethyl fumarate is coming of age.
[Therapy of fatigue in multiple sclerosis : A treatment algorithm].
A case of neuromyelitis optica presenting marked pleocytosis and hypoglycorrhachia.
Magnetic resonance neurography for the evaluation of CIDP.
Follow-up of hypertension in patients with multiple sclerosis.
Magnetization transfer imaging reveals geniculocalcarine and striate area degeneration in primary glaucoma: a preliminary study.
The development of an observational screening tool to assess safe, effective and appropriate walking aid use in people with multiple sclerosis.
Pages
« first
‹ previous
…
786
787
788
789
790
791
792
793
794
…
next ›
last »